In addition, C-type lectin-like molecule 1 (CLL-1), recently reported to be highly expressed in AML blasts, but typically absent in hematopoietic progenitors, has successfully been targeted by either BiTEs or CAR-T cells, in preclinical models of AML [24,25]. Here, CLEC12A is linked to acute myeloid leukemia.